TipRanks
Go Ultimate55% OFF

Allergy Therapeutics (AGYTF) Balance Sheet

Allergy Therapeutics Balance Sheet

Allergy Therapeutics's total assets for Q2 2026 were $71.00M, an increase of 5.12% from the previous quarter. AGYTF total liabilities were $66.75M for the fiscal quarter, a 30.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetJun 25Jun 24Jun 23Jun 22Jun 21
$ 67.54M$ 64.83M$ 66.77M$ 72.95M$ 88.09M
$ 95.74M$ 61.12M$ 64.70M$ 35.18M$ 39.55M
$ -28.19M$ 3.71M$ 2.07M$ 37.77M$ 48.53M

Currency in GBP

Allergy Therapeutics Debt to Assets

040M80M120M40 %80 %120 %160 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets